P-30

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-30
Drug Alias Namediabetes therapy (Phytopharm)P-30
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIXICO plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIXICO plc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A